跳至主要内容
临床试验/CTRI/2023/03/051095
CTRI/2023/03/051095尚未招募3 期

Role of respiratory biofeedback in improving pulmonary function and quality of life in stable C.O.P.D. patients: A Randomized controlled trial

Department of Physical Medicine and Rehabilitation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 40 to 65 years both males and females.
  • 2.Mild to severe stable COPD patients (GOLD Staging 1, 2 and 3).
  • 3.Patients under the care of specialist receiving an accepted medical regimen for COPD for at least 6 weeks.
  • 4.There is no history of psychiatric and neurological disorder.
  • 5.Patients giving consent to participate in this study.

排除标准

  • 1.Patients with very severe COPD (GOLD Staging 4)
  • 2.History of previously known any other chronic lung disease.
  • 3.Patients with co-existing cardiac disease like Congestive heart failure, ischemic heart disease etc.
  • 4.Any bony deformities of spine like scoliosis and kyphosis
  • 5.Patients not willing to participate in study

研究者

相似试验

Role of respiratory biofeedback in improving... | 临床试验